Actinium Pharmaceuticals Files Annual Report and Provides Investor Update
Actinium Pharmaceuticals, Inc. ("Actinium" or the "Company"), a bio pharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers provided investors with an update on its business progress following the filing of its 2015 10-K.
View full press release